Gupta DL, Meher J, Giri AK, Shukla AK, Mohapatra E, Ruikar MM, Rao D. RBD mutations at the residues K417, E484, N501 reduced immunoreactivity with antisera from vaccinated and COVID-19 recovered patients. dti [Internet]. 2024 May 31 [cited 2024 Nov. 23];18(1):20-6. Available from: https://journals.aboutscience.eu/index.php/dti/article/view/3059